144//SEC Filing
Werewolf Therapeutics, Inc. 144
Accession 0001628280-25-053823
CIK 0001691428other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:32 PM ET
Size
287.7 KB
Accession
0001628280-25-053823
Documents
Issuer
UBS Oncology Impact Fund L.P.
CIK 0001691428
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001691428
Filing Metadata
- Form type
- 144
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:32 PM ET
- Size
- 287.7 KB